Chemovirotherapy for Head and Neck Squamous Cell Carcinoma With EGFR-targeted and CD/UPRT-armed Oncolytic Measles Virus

Cancer Gene Therapy - United Kingdom
doi 10.1038/cgt.2011.75
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter for Squamous Cell Cancer of the Head and Neck Radiovirotherapy

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2012English

EGFR Modulates Complement Activation in Head and Neck Squamous Cell Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma Models

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2009English

Head and Neck: Oral Squamous Cell Carcinoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Sentinel Lymph Node Targeted Therapy by Oncolytic Sendai Virus Suppresses Micrometastasis of Head and Neck Squamous Cell Carcinoma in an Orthotopic Nude Mouse Model

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Co-Targeting EGFR and IKKβ/NF-κB Signalling Pathways in Head and Neck Squamous Cell Carcinoma: A Potential Novel Therapy for Head and Neck Squamous Cell Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Head and Neck Squamous Cell Carcinoma Survivorship Care

2019English

Adjuvant Chemotherapy for Advanced Head and Neck Squamous Cell Carcinoma

JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy